THE UBIQUITIN-PROTEASOME SYSTEM IN CANCER: MECHANISMS, TARGETS AND THERAPEUTIC POTENTIAL

Experimental Oncology · Published 2026-03-05 · DOI 10.15407/exp-oncology.2025.04.395

Authors being retrieved — see the publisher record. https://doi.org/10.15407/exp-oncology.2025.04.395

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY · Experimental Oncology · 2025 · Same journal
IMMUNOHISTOCHEMICAL STUDY OF CD44 AND OCT3/4 EXPRESSION IN COLORECTAL CANCER SAMPLES OF IRAQI PATIENTS · Experimental Oncology · 2025 · Same journal
LYMPHOCYTE SUBSET DISTRIBUTION AFTER COMBINED CHEMO- AND RADIOTHERAPY IN PATIENTS WITH CANCER OF THE ORAL CAVITY, OROPHARYNX, AND LARYNGOPHARYNX · Experimental Oncology · 2025 · Same journal
ASSOCIATION OF INTRON 4 VNTR (4A/B) POLYMORPHISM OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE WITH THE INCIDENCE OF BREAST CANCER IN IRAQI WOMEN · Experimental Oncology · 2025 · Same journal
HOMOERIODICTYOL INHIBITS SURVIVAL AND MIGRATION OF ANDROGEN-RESISTANT PROSTATE CANCER CELLS IN VITRO · Experimental Oncology · 2025 · Same journal
CLINICAL RELEVANCE OF HORMONAL RECEPTOR EXPRESSION IN BREAST CANCER: AN IMMUNOHISTOCHEMICAL STUDY FROM TRIPOLI, LIBYA · Experimental Oncology · 2025 · Same journal
LETROZOLE IMPROVES PROGRESSION-FREE SURVIVAL OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH PEGYLATED LIPOSOMAL DOXORUBICIN AND MAGNETOTHERMY · Experimental Oncology · 2025 · Same journal
EVALUATING PERFORMANCE OF COMBINED HEMOGLOBIN AND TRANSFERRIN DETECTION IN FECAL IMMUNOCHEMICAL TESTING FOR COLORECTAL NEOPLASIA · Experimental Oncology · 2025 · Same journal
Clinical Case of Primary Ovarian Osteosarcoma · Experimental Oncology · 2026 · Same journal
ON THE POSSIBLE MECHANISMS OF MICROBIOME INVOLVEMENT IN INDUCTION OF MALIGNANCY · Experimental Oncology · 2025 · Same journal